Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 1924560)

Published in Plast Reconstr Surg on November 01, 1991

Authors

C A Vacanti1, R Langer, B Schloo, J P Vacanti

Author Affiliations

1: Department of Anaesthesiology, Massachusetts General Hospital, Boston.

Articles citing this

Animal models for cartilage regeneration and repair. Tissue Eng Part B Rev (2010) 2.22

Challenges in tissue engineering. J R Soc Interface (2006) 1.70

Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors. Biochem J (2001) 1.17

High-fidelity tissue engineering of patient-specific auricles for reconstruction of pediatric microtia and other auricular deformities. PLoS One (2013) 1.12

The morphology and biomechanical characteristics of subcutaneously implanted tissue-engineered human septal cartilage. Eur Arch Otorhinolaryngol (2005) 0.92

Injectable bioactive glass/biodegradable polymer composite for bone and cartilage reconstruction: concept and experimental outcome with thermoplastic composites of poly(epsilon-caprolactone-co-D,L-lactide) and bioactive glass S53P4. J Mater Sci Mater Med (2004) 0.89

Tissue engineered vascularized bone formation using in vivo implanted osteoblast-polyglycolic acid scaffold. J Korean Med Sci (2005) 0.88

Cell-engineered human elastic chondrocytes regenerate natural scaffold in vitro and neocartilage with neoperichondrium in the human body post-transplantation. Tissue Eng Part A (2012) 0.88

Phenotypic analysis of bovine chondrocytes cultured in 3D collagen sponges: effect of serum substitutes. Cell Tissue Bank (2005) 0.87

CD14-negative isolation enhances chondrogenesis in synovial fibroblasts. Tissue Eng Part A (2009) 0.87

Cartilage and bone tissue engineering for reconstructive head and neck surgery. Eur Arch Otorhinolaryngol (2004) 0.87

Marine collagen scaffolds for nasal cartilage repair: prevention of nasal septal perforations in a new orthotopic rat model using tissue engineering techniques. Tissue Eng Part A (2013) 0.86

Commercial considerations in tissue engineering. J Anat (2006) 0.86

The Maturation of Synthetic Scaffolds for Osteochondral Donor Sites of the Knee: An MRI and T2-Mapping Analysis. Cartilage (2010) 0.86

Behavior of tissue-engineered human cartilage after transplantation into nude mice. J Mater Sci Mater Med (2004) 0.82

Prefabrication of 3D cartilage contructs: towards a tissue engineered auricle--a model tested in rabbits. PLoS One (2013) 0.81

Appropriate nonwoven filters effectively capture human peripheral blood cells and mesenchymal stem cells, which show enhanced production of growth factors. J Artif Organs (2014) 0.81

Effect of growth factors on matrix synthesis by human nasal chondrocytes cultured in monolayer and in agar. Eur Arch Otorhinolaryngol (1996) 0.80

Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineering. Genes Dis (2015) 0.80

Mutually reinforced multicomponent polysaccharide networks. Biopolymers (2011) 0.80

Cardiovascular tissue engineering: where we come from and where are we now? Med Sci Monit Basic Res (2015) 0.80

Bioengineering kidneys for transplantation. Semin Nephrol (2014) 0.79

Evaluation of three-dimensional chitosan-agarose-gelatin cryogel scaffold for the repair of subchondral cartilage defects: an in vivo study in a rabbit model. Tissue Eng Part A (2014) 0.79

Improvement of PHBV scaffolds with bioglass for cartilage tissue engineering. PLoS One (2013) 0.78

Development and characterization of novel porous 3D alginate-cockle shell powder nanobiocomposite bone scaffold. Biomed Res Int (2014) 0.77

Genetic modification of xenografts. Curr Top Microbiol Immunol (2003) 0.77

Augmenting the articular cartilage-implant interface: Functionalizing with a collagen adhesion protein. J Biomed Mater Res A (2012) 0.77

Development of cartilage tissue engineering techniques based on biomedical research. J Orthop Sci (2014) 0.75

Effect of chitosan incorporation and scaffold geometry on chondrocyte function in dense collagen type I hydrogels. Tissue Eng Part A (2013) 0.75

Evaluation of chitosan-GP hydrogel biocompatibility in osteochondral defects: an experimental approach. BMC Vet Res (2014) 0.75

The Challenge and the Promise of Bone Marrow Cells for Human Cartilage Repair. Cartilage (2015) 0.75

Levels of Evidence in the Plastic Surgery Literature: A Citation Analysis of the Top 50 'Classic' Papers. Arch Plast Surg (2015) 0.75

Articles by these authors

Tissue engineering. Science (1993) 19.65

Biodegradable long-circulating polymeric nanospheres. Science (1994) 7.46

Functional arteries grown in vitro. Science (1999) 6.08

A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials (2003) 3.63

Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics (1989) 3.38

Large porous particles for pulmonary drug delivery. Science (1997) 3.35

Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg (1997) 2.93

Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation (1989) 2.91

New challenges in biomaterials. Science (1994) 2.85

Polymers for the sustained release of proteins and other macromolecules. Nature (1976) 2.81

Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci U S A (1997) 2.74

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature (1992) 2.73

Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res (1991) 2.70

Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res (2000) 2.67

Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res (2000) 2.64

Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet (1999) 2.62

Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science (1983) 2.47

Biodegradable polymer scaffolds for tissue engineering. Biotechnology (N Y) (1994) 2.47

A controlled-release microchip. Nature (1999) 2.39

Bioengineered teeth from cultured rat tooth bud cells. J Dent Res (2004) 2.31

Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A (1993) 2.27

Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials (1996) 2.27

Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol (1995) 2.21

Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc Natl Acad Sci U S A (1991) 2.19

Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res (1999) 2.19

Lipid-based nanotherapeutics for siRNA delivery. J Intern Med (2010) 2.15

Formulation and physical characterization of large porous particles for inhalation. Pharm Res (1999) 2.10

Ultrasound-mediated transdermal protein delivery. Science (1995) 2.07

Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog (1998) 2.03

Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. J Am Chem Soc (2001) 2.02

Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01

Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng (1999) 2.00

Transdermal photopolymerization for minimally invasive implantation. Proc Natl Acad Sci U S A (1999) 1.99

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94

Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol (2001) 1.90

Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88

Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. J Pharm Sci (1980) 1.86

In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85

Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg (2001) 1.84

Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol (1992) 1.79

Isolations of a cartilage factor that inhibits tumor neovascularization. Science (1976) 1.79

Identification of an inhibitor of neovascularization from cartilage. Science (1990) 1.78

Functional living trileaflet heart valves grown in vitro. Circulation (2000) 1.77

Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension (2000) 1.77

Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76

Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg (1998) 1.76

Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci U S A (2001) 1.76

Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng (2000) 1.71

Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix. J Cell Sci (1995) 1.71

Tissue engineering of complex tooth structures on biodegradable polymer scaffolds. J Dent Res (2002) 1.61

Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol Biol Cell (1994) 1.61

The stimulation of DNA synthesis and cell division in chondrocytes and 3T3 cells by a growth factor isolated from cartilage. Exp Cell Res (1977) 1.60

A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci (1997) 1.58

Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials (1993) 1.57

Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med (2000) 1.57

Tissue engineering of cartilage in space. Proc Natl Acad Sci U S A (1997) 1.57

Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg (1988) 1.55

Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. J Pediatr (1985) 1.52

Tissue-engineered growth of cartilage: the effect of varying the concentration of chondrocytes seeded onto synthetic polymer matrices. Int J Oral Maxillofac Surg (1994) 1.52

Transdermal photopolymerization of poly(ethylene oxide)-based injectable hydrogels for tissue-engineered cartilage. Plast Reconstr Surg (1999) 1.52

Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res (1997) 1.51

[MRI with supermagnetic iron particles versus double-spiral CT in identification of malignant liver lesions]. Rofo (1998) 1.51

Fallopian tube torsion: laparoscopic evaluation and treatment of a rare gynecological entity. J Am Board Fam Pract (2001) 1.49

Controlled and modulated release of basic fibroblast growth factor. Biomaterials (1991) 1.48

A polymer foam conduit seeded with Schwann cells promotes guided peripheral nerve regeneration. Tissue Eng (2000) 1.48

Collagen in tissue-engineered cartilage: types, structure, and crosslinks. J Cell Biochem (1998) 1.47

Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol (2009) 1.46

Tissue engineering: the challenges ahead. Sci Am (1999) 1.45

Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res (1993) 1.44

Bacterial inactivation by using near- and supercritical carbon dioxide. Proc Natl Acad Sci U S A (1999) 1.43

Purification and characterization of heparinase from Flavobacterium heparinum. J Biol Chem (1985) 1.43

Tissue engineering: current state and prospects. Annu Rev Med (2001) 1.42

Transdermal drug delivery using low-frequency sonophoresis. Pharm Res (1996) 1.42

Chondrogenesis in a cell-polymer-bioreactor system. Exp Cell Res (1998) 1.42

Protein stability in controlled-release systems. Nat Biotechnol (2000) 1.41

Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds. Transplant Proc (1997) 1.41

Silk based biomaterials to heal critical sized femur defects. Bone (2006) 1.40

Responsive polymeric delivery systems. Adv Drug Deliv Rev (2001) 1.40

Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc Natl Acad Sci U S A (1989) 1.39

Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors. Biomaterials (2005) 1.38

Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology (1996) 1.37

Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol (1985) (1998) 1.36

Electrically conducting polymers can noninvasively control the shape and growth of mammalian cells. Proc Natl Acad Sci U S A (1994) 1.33

Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J Biomed Mater Res (1985) 1.33

Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials (2004) 1.32

Tissue engineering: a 21st century solution to surgical reconstruction. Ann Thorac Surg (2001) 1.32

Tissue engineering: current state and perspectives. Appl Microbiol Biotechnol (2004) 1.32

Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine (1994) 1.31

Biomimetic approach to cardiac tissue engineering. Philos Trans R Soc Lond B Biol Sci (2007) 1.31

A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci (1995) 1.30

Fabrication of nanostructures of polyethylene glycol for applications to protein adsorption and cell adhesion. Nanotechnology (2005) 1.30